Login / Signup

Blood-biomarkers in mild cognitive impairment patients: relationship between analytes and progression to Alzheimer's disease dementia.

Anuschka Silva-SpínolaMarisa LimaMaria João LeitãoCatarina BernardesJoão DurãesDiana DuroMiguel Tábuas-PereiraIsabel SantanaInês Baldeiras
Published in: European journal of neurology (2023)
Our findings highlight the potential of combining blood-based GFAP, NfL and p-Tau181 to be applied as a prognostic tool in MCI.
Keyphrases
  • mild cognitive impairment
  • cognitive decline
  • end stage renal disease
  • newly diagnosed
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • risk assessment
  • climate change